Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Eichenfield

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Cutis|December 17, 2009
Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoidLawrence Eichenfield
Cutis|December 17, 2009
Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. IntroductionLawrence Eichenfield
The British Journal of Dermatology|April 22, 2022
Isotretinoin does not contribute to increased neuropsychiatric risk in the overall acne population, but risk management during treatment remains essentialJane Ravencroft, Lawrence Eichenfield
Pediatric Dermatology|November 21, 2015
Introducing: Pediatric Dermatology Procedures and PearlsLawrence Eichenfield, Ilona Frieden
Pediatric Dermatology|February 10, 2016
Walter (Wally) Burgdorf, M.D., 1943-2015Ilona Frieden, Lawrence Eichenfield
F1000Research|November 24, 2018
Recent advances in understanding and preventing peanut and tree nut hypersensitivityAyan Kusari, Allison Han, Lawrence Eichenfield
Journal of the American Academy of Dermatology|December 18, 2017
Emerging therapies for atopic dermatitis: JAK inhibitorsDavid G Cotter, David Schairer, Lawrence Eichenfield
Journal of Drugs in Dermatology : JDD|November 16, 2021
Therapeutic Approaches and Special Considerations for Treating Molluscum ContagiosumLawrence Eichenfield, Adelaide Hebert, Anthony Mancini, et al.
Journal of Drugs in Dermatology : JDD|June 8, 2022
Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% CreamLawrence Eichenfield, Pearl Kwong, Stephanie Lee, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 26, 2011
Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescentsSharon E Jacob, Elise M Herro, Kim Sullivan, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Cutis|December 17, 2009
Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoidLawrence Eichenfield
Cutis|December 17, 2009
Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. IntroductionLawrence Eichenfield
The British Journal of Dermatology|April 22, 2022
Isotretinoin does not contribute to increased neuropsychiatric risk in the overall acne population, but risk management during treatment remains essentialJane Ravencroft, Lawrence Eichenfield
Pediatric Dermatology|November 21, 2015
Introducing: Pediatric Dermatology Procedures and PearlsLawrence Eichenfield, Ilona Frieden
Pediatric Dermatology|February 10, 2016
Walter (Wally) Burgdorf, M.D., 1943-2015Ilona Frieden, Lawrence Eichenfield
F1000Research|November 24, 2018
Recent advances in understanding and preventing peanut and tree nut hypersensitivityAyan Kusari, Allison Han, Lawrence Eichenfield
Journal of the American Academy of Dermatology|December 18, 2017
Emerging therapies for atopic dermatitis: JAK inhibitorsDavid G Cotter, David Schairer, Lawrence Eichenfield
Journal of Drugs in Dermatology : JDD|November 16, 2021
Therapeutic Approaches and Special Considerations for Treating Molluscum ContagiosumLawrence Eichenfield, Adelaide Hebert, Anthony Mancini, et al.
Journal of Drugs in Dermatology : JDD|June 8, 2022
Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% CreamLawrence Eichenfield, Pearl Kwong, Stephanie Lee, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 26, 2011
Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescentsSharon E Jacob, Elise M Herro, Kim Sullivan, et al.
Pageof 6